EurekAlert! InContext Modules

Public Release: 22-May-2012
New initiative aims to increase mobility for disabled children worldwide
A team of global partners has tasked itself with the daunting challenge of bringing mobility to disabled children of developing nations through the Lifelong Mobility Project.

The Benter Foundation

Public Release: 22-May-2012

PLOS ONE
Newly discovered breast milk antibodies help neutralize HIV
Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, and showed that the B cells in breast milk can generate neutralizing antibodies that may inhibit the virus that causes AIDS.

National Institutes of Health, Doris Duke Foundation Clinical Scientist Development Award, Gates Foundation, others

Public Release: 22-May-2012
UC San Diego Superfund Research Program receives $15 million grant renewal
The National Institute of Environmental Health Sciences, part of the National Institutes of Health, has renewed funding for the Superfund Research Program at the University of California, San Diego. Over the next five years, the $15 million grant will fund continued research on the molecular and genetic consequences of exposure to uncontrolled toxicants from Superfund and other hazardous waste sites.

NIH/National Institute of Environmental Health Sciences

Public Release: 22-May-2012

Dissertations and Features
Better tests for sleeping sickness
Lies Van Nieuwenhove, researcher at the Antwerp Institute of Tropical Medicine, has produced proteins imitating typical parts of the sleeping sickness parasite. They can be used in more efficient diagnostic tests, without the need for culturing dangerous parasites.

Public Release: 21-May-2012

Biomedical Optics Express
New microscope uses rainbow of light to image the flow of individual blood cells
Blood tests convey vital medical information, but the sight of a needle often causes anxiety and results take time. A new device developed by a team of researchers in Israel, however, can reveal much the same information as a traditional blood test in real-time, simply by shining a light through the skin. This portable optical instrument is able to provide high-resolution images of blood coursing through veins without the need for harsh fluorescent dyes.

Public Release: 21-May-2012
Sustainable R&D framework needed to address essential health needs of developing countries
The Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, welcomes the experts' conclusion that 'the time has now come for WHO Member States to begin a process leading to the negotiation of a binding agreement on R&D relevant to the health needs of developing countries'.

Public Release: 21-May-2012

Lancet Infectious Diseases
NIH study shows poor quality malaria drugs pose threat
Poor quality antimalarial drugs lead to drug resistance and inadequate treatment that pose an urgent threat to vulnerable populations, according to a National Institutes of Health study published May 22 in the Lancet Infectious Diseases journal. Emergence of malaria strains that are resistant to artemisinin drugs on the Thailand-Cambodia border make it imperative to improve the drug supply, stressed the authors.

NIH/Fogarty International Center, National Institutes of Health

Public Release: 20-May-2012

Nature Medicine
Drug found for parasite that is major cause of death worldwide
Research by a collaborative group of scientists from UC San Diego School of Medicine, UC San Francisco and Wake Forest School of Medicine has led to identification of an existing drug that is effective against Entamoeba histolytica. This parasite causes amebic dysentery and liver abscesses and results in the death of more than 70,000 people worldwide each year.

Sandler Foundation, NIH/National Institute of Allergy and Infectious Diseases

Public Release: 20-May-2012

Nature Medicine
Lab tests show arthritis drug effective against global parasite
A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.

Sandler Foundation, NIH/National Institute of Allergy and Infectious Diseases

Public Release: 17-May-2012

Science
'Rare' genetic variants are surprisingly common, life scientists report
A large survey of human genetic variation, published today in the online version of the journal Science, shows that rare genetic variants are not so rare after all, and offers insights into human diseases. A team of scientists studied 202 genes in 14,002 people -- one of the largest ever in a sequencing study in humans.

Public Release: 17-May-2012

International Journal of Computers in Healthcare
Bluetooth baby
Checking the heart of the unborn baby usually involves a stethoscope. However, an inexpensive and accurate Bluetooth fetal heart rate monitoring system has now been developed by researchers in India for long-term home care. Details are reported in a forthcoming issue of the International Journal of Computers in Healthcare.

Public Release: 16-May-2012

Nature Medicine
Scientists uncover potential treatment for painful side effect of diabetes
Research published in the journal Nature Medicine reveals that a multinational collaboration between scientists from Warwick Medical School in the UK, and universities in Germany, New York, Australia and Eastern Europe, has discovered key information around one of the most distressing side effects of diabetes.

Public Release: 16-May-2012

New England Journal of Medicine
In drug-approval race, US FDA ahead of Canada, Europe
The US Food and Drug Administration generally approves drug therapies faster and earlier than its counterparts in Canada and Europe, according to a new study by Yale School of Medicine researchers. The study counters perceptions that the drug approval process in the United States is especially slow.

Pew Charitable Trusts

Public Release: 15-May-2012

JAMA
Considerable prevalence of both malaria, STIs exist among pregnant women in sub-Saharan Africa
A review of studies reporting estimates of the prevalence of sexually transmitted infections/reproductive tract infections (STIs/RTIs) and malaria over the past 20 years suggests that a considerable burden of malaria and STIs/RTIs exists among pregnant women attending antenatal (before birth) facilities in sub-Saharan Africa, according to a review and meta-analysis of previous studies published in the May 16 issue of JAMA, a theme issue on global health.

Public Release: 15-May-2012
GBCHealth Conference introduces MDG Health Alliance
The MDG Health Alliance, an innovative new private sector organization created and led by eminent business leaders to tackle urgent global health problems, was introduced today in the United States at the GBCHealth Conference.

Public Release: 15-May-2012

JAMA
New treatment could tackle preventable causes of death for newborns in sub-Saharan Africa
Researchers have found an alarming prevalence of malaria and sexually transmitted infections among pregnant women in sub-Saharan Africa. Urgent clinical trials are now being conducted to test a new dual-treatment that could save the lives of many new born babies.

Public Release: 14-May-2012
Washington University receives $8 million to lead international childhood malnutrition effort
Jeffrey I. Gordon, M.D., at Washington University School of Medicine in St. Louis, will lead an international team of scientists to find new ways to diagnose, treat and prevent a critical global health problem: malnutrition in infants and children. The work is funded by an $8.3 million grant from the Bill and Melinda Gates Foundation.

Bill and Melinda Gates Foundation

Public Release: 14-May-2012

Nature
Cellular secrets of plant fatty acid production understood
A curious twist in a family of plant proteins called chalcone-isomerase recently was discovered by Salk Institute for Biological Studies scientist Joseph Noel and colleagues at Iowa State University led by Eve Wurtele.

National Science Foundation

Public Release: 11-May-2012
2 Grand Challenges Explorations grants for global health
The innovative research of three Northwestern University professors who are making a big difference in the highly promising area of synthetic biology has been recognized with two early-stage discovery awards from Grand Challenges Explorations, an initiative funded by the Bill and Melinda Gates Foundation. The global health projects will focus on creating new compounds to combat malaria and on producing biosensors for low-cost, in-home diagnoses.

Bill and Melinda Gates Foundation

Public Release: 11-May-2012
Lawson recieves Grand Challenges Explorations grant for groundbreaking research
Lawson Health Research Institute announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Dr. Gregor Reid and his team are the first London, Ontario-based researchers to receive funding from the Gates Foundation. The research project will study the impact of probiotic yogurt mixed with the nutrient rich plant called Moringa on the health outcomes of pregnant women and their children.

Bill & Melinda Gates Foundation

Public Release: 10-May-2012
NJIT hemophilia expert to speak at Medical History Society on May 16
NJIT Associate Professor Stephen Pemberton will speak about hemophilia to physicians on May 16, 2012 in Princeton at the Nassau Club at a special meeting of the Medical History Society of New Jersey.

Public Release: 10-May-2012

Science
'Gut'-throat competition: Research on digestive tract bacteria yields surprising findings
From tiny villages in developing nations to suburban kitchens in the United States, dangerous strains of E. coli bacteria sicken millions of people each year – and kill untold numbers of children. Now, new research gives scientists a better understanding of what is going on in the diarrhea-wracked guts of its victims, and what might be done to prevent or treat it.

National Institutes of Health, and others

Public Release: 10-May-2012

31st ESTRO Congress and the World Congress of Brachytherapy
3-D image guided brachytherapy helps avoid hysterectomies for cervical cancer patients
Delivering radiotherapy directly to cancer of the cervix using 3-D imaging techniques is effective at controlling the return and spread of the disease and, in most cases, avoids the need for hysterectomies. Results of this technique are for superior to those from previous eras using different treatments, and it has fewer side effects, researchers will tell the World Congress of Brachytherapy on Thursday.

Public Release: 9-May-2012
Biosensor illuminates compounds to aid fight against TB
For his work on developing new treatments for tuberculosis, a Michigan State University researcher has been named a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Robert Abramovitch of MSU's Department of Microbiology and Molecular Genetics is using a synthetic biosensor that glows green in response to conditions that mimic human tuberculosis infection.

Bill & Melinda Gates Foundation

Public Release: 9-May-2012

Proteome Science
Advanced genetic screening method may speed vaccine development
Vaccines remain the best line of defense against deadly pathogens and now Kathryn Sykes and Stephen Johnston, researchers at Arizona State University's Biodesign Institute, along with co-author Michael McGuire from the University of Texas Southwestern Medical Center are using clever functional screening methods to attempt to speed new vaccines into production that are both safer and more potent.


			HOME DISCLAIMER PRIVACY POLICY TERMS & CONDITIONS CONTACT US TOP Copyright ©2013 by AAAS, the science society.